West Branch Capital’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.49M | Buy |
33,416
+34
| +0.1% | +$7.92K | 1.97% | 14 |
|
|
2026
Q1 | $8.16M | Sell |
33,382
-99
| -0.3% | -$23.1K | 2.18% | 12 |
|
|
2025
Q4 | $6.93M | Buy |
33,481
+432
| +1% | +$85.4K | 1.79% | 16 |
|
|
2025
Q3 | $6.13M | Buy |
33,049
+519
| +2% | +$88.9K | 1.61% | 17 |
|
|
2025
Q2 | $4.97M | Buy |
32,530
+7,130
| +28% | +$1.1M | 1.47% | 20 |
|
|
2025
Q1 | $4.21M | Buy |
25,400
+1,866
| +8% | +$292K | 1.41% | 20 |
|
|
2024
Q4 | $3.4M | Sell |
23,534
-1,356
| -5% | -$210K | 1.09% | 21 |
|
|
2024
Q3 | $4.03M | Buy |
24,890
+688
| +3% | +$110K | 1.39% | 18 |
|
|
2024
Q2 | $3.54M | Buy |
24,202
+245
| +1% | +$36.4K | 1.31% | 19 |
|
|
2024
Q1 | $3.79M | Buy |
23,957
+1,195
| +5% | +$190K | 1.53% | 17 |
|
|
2023
Q4 | $3.57M | Sell |
22,762
-1,029
| -4% | -$158K | 1.68% | 15 |
|
|
2023
Q3 | $3.71M | Buy |
23,791
+50
| +0.2% | +$8.25K | 1.94% | 13 |
|
|
2023
Q2 | $3.93M | Buy |
23,741
+595
| +3% | +$96K | 1.96% | 11 |
|
|
2023
Q1 | $3.59M | Buy |
23,146
+133
| +0.6% | +$21.5K | 2% | 13 |
|
|
2022
Q4 | $4.07M | Buy |
23,013
+38
| +0.2% | +$6.56K | 2.51% | 11 |
|
|
2022
Q3 | $3.75M | Buy |
22,975
+316
| +1% | +$53.5K | 2.33% | 11 |
|
|
2022
Q2 | $4.02M | Sell |
22,659
-241
| -1% | -$42.9K | 2.33% | 10 |
|
|
2022
Q1 | $4.06M | Sell |
22,900
-563
| -2% | -$95.8K | 1.94% | 10 |
|
|
2021
Q4 | $4.01M | Buy |
23,463
+80
| +0.3% | +$13.1K | 1.71% | 13 |
|
|
2021
Q3 | $3.78M | Sell |
23,383
-119
| -0.5% | -$20.3K | 1.82% | 13 |
|
|
2021
Q2 | $3.87M | Buy |
23,502
+422
| +2% | +$69.9K | 1.9% | 12 |
|
|
2021
Q1 | $3.79M | Sell |
23,080
-367
| -2% | -$59.4K | 2.22% | 12 |
|
|
2020
Q4 | $3.69M | Buy |
23,447
+240
| +1% | +$35.4K | 2.18% | 12 |
|
|
2020
Q3 | $3.46M | Buy |
23,207
+103
| +0.4% | +$15.2K | 2.2% | 11 |
|
|
2020
Q2 | $3.25M | Buy |
23,104
+4,733
| +26% | +$690K | 2.29% | 10 |
|
|
2020
Q1 | $2.41M | Buy |
18,371
+168
| +0.9% | +$23.8K | 2.3% | 12 |
|
|
2019
Q4 | $2.65M | Buy |
18,203
+6,663
| +58% | +$904K | 1.85% | 14 |
|
|
2019
Q3 | $1.49M | Sell |
11,540
-6,088
| -35% | -$802K | 1.11% | 26 |
|
|
2019
Q2 | $2.46M | Sell |
17,628
-42
| -0.2% | -$5.81K | 2.03% | 14 |
|
|
2019
Q1 | $2.47M | Buy |
17,670
+352
| +2% | +$47.1K | 2.21% | 12 |
|
|
2018
Q4 | $2.23M | Sell |
17,318
-528
| -3% | -$73.7K | 2.35% | 12 |
|
|
2018
Q3 | $2.47M | Sell |
17,846
-74
| -0.4% | -$9.83K | 1.83% | 15 |
|
|
2018
Q2 | $2.17M | Buy |
17,920
+9,345
| +109% | +$1.17M | 1.71% | 18 |
|
|
2018
Q1 | $1.1M | Buy |
+8,575
| New | +$1.16M | 1.21% | 28 |
|
Other funds holding JNJ
AACR
West Branch Capital's JNJ Position: Q2 2026 in Review
West Branch Capital increased its Johnson & Johnson (JNJ) stake by 0.1% in Q2 2026, buying an estimated $7.92K and bringing the position to 33,416 shares worth $8.49M. The position accounts for 1.97% of the portfolio, ranked #14.
West Branch Capital first reported a position in JNJ in Q1 2018 and has held it in 34 quarters since. 2,235 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- West Branch Capital held 33,416 shares of Johnson & Johnson worth $8.49M as of Q2 2026.
- West Branch Capital bought 34 Johnson & Johnson shares in Q2 2026, an estimated $7.92K.
- Johnson & Johnson made up 1.97% of West Branch Capital's portfolio in Q2 2026, its #14 holding.
- West Branch Capital first reported a position in Johnson & Johnson in Q1 2018 and has held it in 34 quarters since.
- 2,235 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on West Branch Capital's 13F filing for Q2 2026, filed 10 Jul 2026.